Wednesday 5 June 2019
16:00-17:30
Hall 1C		 Reshaping the landscape of cystic fibrosis treatment options for people with cystic fibrosis – novel CFTR modulator combinations
Moderator: Patrick Flume, Charleston, US 
16:00 – 16:15 The evolving CFTR modulator landscape – Patrick Flume, Charleston, US 
16:15 – 16:35 Unmet needs: the patient experience – Jane Davies, London, UK
16:35 – 16:55 New CFTR modulator combinations: new possibilities – Damian Downey, Belfast, UK
16:55 – 17:15 Personalised approach to CFTR modulator therapy – Jeffrey Beekman, Utrecht, NL
17:15 – 17:30 Questions and moderator’s close
Thursday 6 June 2019
07:15 – 08:15
Hall 1B		 Management of cystic fibrosis: mucus in focus      
Moderator: Jane Davies, London, UK
07:15 – 07:20 Introduction
07:20 – 07:35 Imaging and management of mucus in today’s cystic fibrosis patients – Harm Tiddens, Rotterdam, NL
07:35 – 07:50 Power in numbers: harnessing registry data on mucoactive treatments – Edward McKone, Dublin, IE
07:50 – 08:05 What do treatment guidelines tell us? NICE and beyond – Jane Davies, London, UK
08:05 – 08:15 Panel discussion and questions
Thursday 6 June 2019
12:30-14:00
Hall 1A		 Where next for cystic fibrosis management? Windows of opportunity
Moderator: Marcus Mall, Berlin, DE    
12:30 – 12:40 Welcome and introduction – Marcus Mall, Berlin, DE 
12:40 – 12:55 Slowing cystic fibrosis progression: windows of opportunity – Marcus Mall, Berlin, DE 
12:55 – 13:20 Assessing lung disease: which modality? – Alex Horsley, Manchester, UK 
13:20 – 13:45 Advancing understanding: nutrition, growth and the exocrine pancreas – Tanja Gonska, Toronto, CA   
13:45 – 14:00 Questions and close
Friday 7 June 2019
07:15 – 08:15
Hall 1B		 Computational fluid dynamics and lung deposition
Moderator: Kevin Southern, Liverpool, UK    
07:15 – 07:25 Welcome and introduction – Kevin Southern, Liverpool, UK 
07:25 – 08:05 How does your patient breathe? Computational fluid dynamics and lung deposition – Jan De Backer, Antwerp, BE / Charles Haworth, Cambridge, UK / Tracey Daniels, York, UK 
08:05 – 08:15 Questions and moderator’s close 
Friday 7 June 2019
12:30-14:00
Room 11 (ABC)		 Inhaled antibiotic therapy: broadening the options in cystic fibrosis
 
12:30 – 13:00 A view on the complex microbiome in cystic fibrosis – Marco Cipolli, Ancona, IT
13:00 – 13:30  Nebulised levofloxacin: data from clinical trials – Damian Downey, Belfast, UK
13:30 – 14:00 Clinical experience in the use of nebulised levofloxacin – Carsten Schwarz, Berlin, DE 
Friday 7 June 2019
12:30-14:00
Hall 2E		 Cystic fibrosis: a 30-year journey from gene to therapy
Moderator: Stuart Elborn, Belfast, UK     
12:30 – 12:40 Welcome and introduction Stuart Elborn, Belfast, UK 
12:40 – 13:00 Thirty years from gene discovery to precision medicine – understanding the science behind the Vertex discovery and development of CFTR modulators – Fred Van Goor, San Diego, US
13:00 – 13:20 What does the future hold?
Looking beyond protein modulation – gene therapy – Eric Alton, London, UK 
13:20 – 13:40 What does the future hold? 
Looking beyond protein modulation – gene editing – Patrick Harrison, Cork, IE 
13:40 – 14:00 Discussion, questions and moderator’s close